📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Ubiquitin/UBL Drug Target Repertoire. (2020)

First Author: Osborne HC

Attributed to: Exploring the potential of ubiquitin UBE2D inhibitors as novel anti-cancer treatments funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.molmed.2020.08.009

PubMed Identifier: 32981839

Publication URI: http://europepmc.org/abstract/MED/32981839

Type: Journal Article/Review

Volume: 26

Parent Publication: Trends in molecular medicine

Issue: 12

ISSN: 1471-4914